Search Results - BC Cancer Agency Library

Cell surface antigens in normal and neoplastic human B lymphocyte differentiation : cellular distribution and functional implications

https://bccalibrary.andornot.com/en/permalink/catalog4774

Howard, Donald Raymond. [Vancouver, BC?]: Donald Raymond Howard , 1985.

Audience: Professional

Call Number: QZ202 H848 1985

Availability: 1 copy, 1 available

Author: Howard, Donald Raymond

Place of Publication: [Vancouver, BC?]

Publisher: Donald Raymond Howard

Publication Date: 1985

Subjects: Antigens, Differentiation, T Lymphocyte; B Lymphocytes

Language: English

Material Type: Book; Thesis

Audience: Professional

Location: Vancouver Library

Call Number: QZ202 H848 1985

Copies

c.1 BC Cancer Agency VAN Library

Available

Characterization of SaBR, a novel murine cell surface protein

https://bccalibrary.andornot.com/en/permalink/catalog10112

Sexton, Tracy Lynne. [Vancouver, BC?]: University of British Columbia , 1998.

Audience: Professional

Call Number: WH140 S518 1998

Availability: 1 copy, 1 available

Author: Sexton, Tracy Lynne

Place of Publication: [Vancouver, BC?]

Publisher: University of British Columbia

Publication Date: 1998

Subjects: Somatomedins; Hematopoietic Stem Cells

Language: English

Material Type: Book; Thesis

Audience: Professional

Location: Vancouver Library

Call Number: WH140 S518 1998

Copies

c.1 BC Cancer Agency VAN Library

Available

Cloning and characterization of SH2-containing inositol 5-phosphatase, SHIP

https://bccalibrary.andornot.com/en/permalink/catalog9451

Ware, Mark Daniel. [Vancouver, BC?]: University of British Columbia , 2000.

Audience: Professional

Call Number: QZ206 W271 2000

Availability: 1 copy, 1 available

Author: Ware, Mark Daniel

Place of Publication: [Vancouver, BC?]

Publisher: University of British Columbia

Publication Date: 2000

Subjects: Inositol Phosphates; Cloning, Organism

Language: English

Material Type: Book; Thesis

Audience: Professional

Location: Vancouver Library

Call Number: QZ206 W271 2000

Copies

c.1 BC Cancer Agency VAN Library

Available

Cloning and annotation of novel transcripts from human embryonic stem cells

https://bccalibrary.andornot.com/en/permalink/catalog16511

Khattra, Jaswinder. [Vancouver, BC?]: University of British Columbia , 2007.

Audience: Professional

Call Number: LE3 2007 K45

Availability: 1 copy, 1 available

Author: Khattra, Jaswinder

Place of Publication: [Vancouver, BC?]

Publisher: University of British Columbia

Publication Date: 2007

Physical Description: xxiii, 72 p. : ill. ; 28 cm.

Subjects: Cloning, Organism; TNK1 protein, human; Stem Cells; RNA - analysis

Language: English

Material Type: Book; Thesis

Audience: Professional

Location: Vancouver Library

Call Number: LE3 2007 K45

Copies

c.1 BC Cancer Agency VAN Library

Available

Chimeric antigen receptor t-cell therapies for cancer : a practical guide

https://bccalibrary.andornot.com/en/permalink/catalog122174

Cambridge, MA: Elsevier, Inc. , 2020.

Audience: Professional

Call Number: QZ266 C538 2020

Availability: 3 copies, 3 available

Contents:; Introduction -- When to refer a patient for CAR-T cell therapy -- Optimizing the apheresis product -- CAR T cells: cell processing laboratory considerations -- Peri-CAR-T cell management -- Management of cytokine release syndrome -- Special considerations for ICU management of patients r…

Editor: Lee, Daniel W.; Shah, Nirali N.

Place of Publication: Cambridge, MA

Publisher: Elsevier, Inc.

Publication Date: 2020

Physical Description: xiv, 229 p. : ill. ; 24 cm.

Subjects: Neoplasms - therapy; Receptors, Chimeric Antigen - therapeutic use; Receptors, Antigen, T-Cell; Immunotherapy, Adoptive - methods; Cell- and Tissue-Based Therapy

Abstract: Contents:; Introduction -- When to refer a patient for CAR-T cell therapy -- Optimizing the apheresis product -- CAR T cells: cell processing laboratory considerations -- Peri-CAR-T cell management -- Management of cytokine release syndrome -- Special considerations for ICU management of patients receiving CAR therapy -- Neurotoxicities after CAR-T cell immunotherapy -- Hematologic and non-CRS toxicities -- Response assessment and post-CAR-T cell therapy management -- Relapse management and role for consolidative hematopoietic stem cell transplantation following CAR-T cell therapy -- Promising chimeric antigen receptors for non-B cell hematological malignancies, pediatric solid tumors, and carcinomas -- CAR T cell therapy for CNS malignancies -- CAR 2.0: the next generation of synthetic receptor-based cellular therapy for cancer.